Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Case series analysis of adverse reactions to vaccines: a comparative evaluation.

Farrington CP, Nash J, Miller E.

Am J Epidemiol. 1996 Jun 1;143(11):1165-73. Review. Erratum in: Am J Epidemiol 1998 Jan 1;147(1):93.

PMID:
8633607
2.

The MMR question.

Gallup R.

Lancet. 2000 Jul 8;356(9224):161-2. No abstract available.

PMID:
10963267
3.

Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association.

DeStefano F, Chen RT.

J Pediatr. 2000 Jan;136(1):125-6. No abstract available.

PMID:
10681219
4.

The MMR question.

Thrower D.

Lancet. 2000 Jul 8;356(9224):161. No abstract available.

PMID:
10963266
5.

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E.

Lancet. 1995 Mar 4;345(8949):567-9.

PMID:
7619183
6.

Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.

D'Souza RM, Campbell-Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F, O'Brien E.

Commun Dis Intell. 2000 Feb 17;24(2):27-33.

7.

The MMR question.

Iizuka M, Itou H, Chiba M, Shirasaka T, Watanabe S.

Lancet. 2000 Jul 8;356(9224):160. No abstract available.

PMID:
10963263
8.

The Measles Control Campaign and immunisation adverse events.

Burgess MA, Heath TC, McIntyre PB.

Commun Dis Intell. 1998 Jul 9;22(7):136-8. No abstract available.

9.

Transverse myelitis after measles, mumps, and rubella vaccine.

Joyce KA, Rees JE.

BMJ. 1995 Aug 12;311(7002):422. No abstract available.

10.

Transverse myelitis unlikely to be due to measles, mumps, and rubella vaccine.

Fescharek R, Dass H.

BMJ. 1995 Dec 16;311(7020):1642. No abstract available.

11.

Revaccination against measles and rubella.

Cutts FT.

BMJ. 1996 Mar 9;312(7031):589-90. No abstract available.

12.

Mumps meningitis and measles, mumps, and rubella vaccine.

Colville A, Pugh S.

Lancet. 1992 Sep 26;340(8822):786. No abstract available. Erratum in: Lancet 1992 Dec 5;340(8832):1420. Lancet 1992 Oct 17;340(8825):986.

PMID:
1356189
13.

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project.

Black S, Shinefield H, Ray P, Lewis E, Chen R, Glasser J, Hadler S, Hardy J, Rhodes P, Swint E, Davis R, Thompson R, Mullooly J, Marcy M, Vadheim C, Ward J, Rastogi S, Wise R.

Pediatr Infect Dis J. 1997 May;16(5):500-3.

PMID:
9154545
14.

Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.

Vlacha V, Forman EN, Miron D, Peter G.

Pediatrics. 1996 May;97(5):738-9. No abstract available.

PMID:
8628619
15.

Gianotti-Crosti syndrome after measles, mumps and rubella vaccination.

Velangi SS, Tidman MJ.

Br J Dermatol. 1998 Dec;139(6):1122-3. No abstract available.

PMID:
9990393
16.

Acute idiopathic thrombocytopenic purpura following combined vaccination against measles, mumps, and rubella.

Chang SK, Farrell DL, Dougan K, Kobayashi B.

J Am Board Fam Pract. 1996 Jan-Feb;9(1):53-5. No abstract available.

PMID:
8770810
18.

Modified varicella-like syndrome in children previously vaccinated with live attenuated measles, mumps, rubella and varicella vaccine.

Walter EB, Simmons SS, Bland CL, Clements DA.

Pediatr Infect Dis J. 1997 Jun;16(6):626-7. No abstract available.

PMID:
9194116
19.

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

Dourado I, Cunha S, Teixeira MG, Farrington CP, Melo A, Lucena R, Barreto ML.

Am J Epidemiol. 2000 Mar 1;151(5):524-30.

PMID:
10707922
20.

Indications for measles-mumps-rubella vaccination in a child with prior thrombocytopenia purpura.

Pool V, Chen R, Rhodes P.

Pediatr Infect Dis J. 1997 Apr;16(4):423-4. No abstract available.

PMID:
9109153

Supplemental Content

Support Center